National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
73.17
-1.46 (-1.96%)
May 14, 2025, 4:00 PM - Market closed
National Health Investors Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for National Health Investors stock ranges from a low of $69 to a high of $92. The average analyst price target of $82.2 forecasts a 12.34% increase in the stock price over the next year.
Price Target: $82.20 (+12.34%)
Analyst Consensus: Buy
* Price targets were last updated on Mar 19, 2025.
Analyst Ratings
The average analyst rating for National Health Investors stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $70 → $76 | Hold | Maintains | $70 → $76 | +3.87% | Mar 19, 2025 |
| Wedbush | Wedbush | Buy Reiterates $88 | Buy | Reiterates | $88 | +20.27% | Mar 17, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $78 → $72 | Hold | Maintains | $78 → $72 | -1.60% | Dec 23, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Initiates $81 → $86 | Buy → Hold | Initiates | $81 → $86 | +17.53% | Oct 1, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $92 | Strong Buy | Initiates | $92 | +25.73% | Sep 24, 2024 |
Financial Forecast
Revenue This Year
358.29M
from 335.58M
Increased by 6.77%
Revenue Next Year
400.43M
from 358.29M
Increased by 11.76%
EPS This Year
3.15
from 3.13
Increased by 0.61%
EPS Next Year
3.32
from 3.15
Increased by 5.52%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 416.8M | 512.5M | 601.7M | ||
| Avg | 358.3M | 400.4M | 437.6M | ||
| Low | 325.3M | 337.6M | 342.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 24.2% | 43.0% | 50.3% | ||
| Avg | 6.8% | 11.8% | 9.3% | ||
| Low | -3.1% | -5.8% | -14.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.42 | 3.61 | 3.50 |
| Avg | 3.15 | 3.32 | 3.36 |
| Low | 2.95 | 3.12 | 3.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 9.4% | 14.7% | 5.2% |
| Avg | 0.6% | 5.5% | 1.2% |
| Low | -5.8% | -1.0% | -1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.